China Nepstar Competition
Now Viewing China Nepstar's competition in: Drugstores (primary)
Recent Developments
At-home Paternity Testing Kits Available at Drugstores - Rite Aid is selling an at-home paternity testing kit. Samples taken at home are sent to laboratories owned and operated by Identigene, the testing kit manufacturer, which says that results are 99.99 percent accurate.
Drugstore Construction Continues Rising - The value of drugstore construction spending, which has risen steadily since November 2007, rose 66.9 percent in February 2008 compared to February 2007. Demand for pharmaceuticals and healthcare products is expected to increase as baby boomers age; drugstore construction spending is likely to remain strong as a result.
Legislation Targets Counterfeit Drugs - A bill introduced in Congress in April 2008 is intended to reduce the sale of counterfeit pharmaceuticals in the US. The Safeguarding America's Pharmaceuticals Act of 2008 would mandate electronic pedigree requirements to help track and trace prescription drugs in the domestic supply chain. The National Association of Chain Drug Stores, which opposes the legislation, argues that electronic pedigree and track and trace systems are many years away from full development, haven't been fully tested, and lack uniform standards and patient privacy safeguards.
Competitive Landscape
Demand is driven by the aging of the US population and advances in medical treatment. The profitability of individual companies depends on access to medical insurance groups. Large companies have economies of scale in purchasing and in access to large groups of customers. Small companies can compete effectively through convenient location or special merchandising. Average annual revenue per employee is close to $200,000.
Drugstores Industry Forecast
from Hoover's/D&B subsidiary First Research
US personal consumption expenditures for drug preparations and sundries, which are major indicators for drug stores, are forecast to grow at an annual compounded rate of 10.1 percent between 2007 and 2012.
Consumer Drug and Sundries Spending Growth Strong and Steady
First Research forecasts are based on INFORUM forecasts that are licensed from the Interindustry Economic Research Fund, Inc. (IERF) in College Park, MD. INFORUM's "interindustry-macro" approach to modeling the economy captures the links between industries and the aggregate economy.

First Research Opportunity Rating
The First Research Opportunity Rating is First Research's estimate of industry performance vs. industry risk over the next 12 to 24 months.

- Demand: Increased sales of non-drug items
- Economies of scale favor chains
- Risk: Insurers squeeze drug prices
Industries Where China Nepstar Competes
- Retail
- Drug Stores & Pharmacies (primary)
- Cosmetics, Beauty Supply & Perfume Retail
- Health Care
- Health Care Products
- Pharmaceuticals






